RU2010122954A - COMPOSITION FOR TREATMENT OF VIRAL AND ONCOLOGICAL ANIMAL DISEASES - Google Patents
COMPOSITION FOR TREATMENT OF VIRAL AND ONCOLOGICAL ANIMAL DISEASES Download PDFInfo
- Publication number
- RU2010122954A RU2010122954A RU2010122954/15A RU2010122954A RU2010122954A RU 2010122954 A RU2010122954 A RU 2010122954A RU 2010122954/15 A RU2010122954/15 A RU 2010122954/15A RU 2010122954 A RU2010122954 A RU 2010122954A RU 2010122954 A RU2010122954 A RU 2010122954A
- Authority
- RU
- Russia
- Prior art keywords
- interferon
- composition according
- subspecies
- mixture
- composition
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
1. Композиция для лечения вирусных и онкологических заболеваний животных, содержащая два и более подвида рекомбинантного интерферона позвоночных животных, где содержание каждого из подвидов интерферона в смеси находится в пределах 0,01%-99,99% и суммарно составляя 100%. ! 2. Композиция по п.1, отличающаяся тем, что подвиды рекомбинантного интерферона в смеси представляют собой альфа интерферон, омега интерферон или смесь альфа и омега интерферонов позвоночных животных. ! 3. Композиция по п.1, отличающаяся тем, что она дополнительно необязательно может содержать в своем составе фармацевтические ингредиенты, которые могут быть использованы в составе лекарственных форм, и представляют собой абсорбенты, буферы, красители, отдушки, растворители, смачивающие агенты, покрытия, подсластители, антиоксиданты и пластификаторы. ! 4. Композиция по п.1, отличающаяся тем, что она представлена в различных дозированных лекарственных формах, включая таблетки, капсулы, порошки, распыляемые растворы, аэрозоли, водные растворы, эликсиры и сиропы. ! 5. Композиция по п.1, отличающаяся тем, что ее вводят позвоночному животному оральным, интраназальным, ректальным, парентеральным или ингаляционным способом. 1. Composition for the treatment of viral and oncological diseases of animals, containing two or more subspecies of recombinant interferon of vertebrate animals, where the content of each of the interferon subspecies in the mixture is in the range of 0.01% -99.99% and a total of 100%. ! 2. The composition according to claim 1, characterized in that the subspecies of recombinant interferon in the mixture are alpha interferon, omega interferon or a mixture of alpha and omega interferon vertebrates. ! 3. The composition according to claim 1, characterized in that it additionally optionally may contain pharmaceutical ingredients that can be used in dosage forms, and are absorbents, buffers, dyes, perfumes, solvents, wetting agents, coatings, sweeteners, antioxidants and plasticizers. ! 4. The composition according to claim 1, characterized in that it is presented in various dosage forms, including tablets, capsules, powders, nebulized solutions, aerosols, aqueous solutions, elixirs and syrups. ! 5. The composition according to claim 1, characterized in that it is administered to the vertebrate by oral, intranasal, rectal, parenteral or inhalation route.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010122954/15A RU2482871C2 (en) | 2010-06-07 | 2010-06-07 | Composition for treating viral diseases in animals |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010122954/15A RU2482871C2 (en) | 2010-06-07 | 2010-06-07 | Composition for treating viral diseases in animals |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010122954A true RU2010122954A (en) | 2011-12-20 |
RU2482871C2 RU2482871C2 (en) | 2013-05-27 |
Family
ID=45403665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010122954/15A RU2482871C2 (en) | 2010-06-07 | 2010-06-07 | Composition for treating viral diseases in animals |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2482871C2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2576814C1 (en) * | 2014-10-10 | 2016-03-10 | Общество с ограниченной ответственностью "Научно-Технологический Центр "БиоИнвест" | Agent for treatment and prophylaxis of natural infectious diseases in cats |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1140144A4 (en) * | 1998-12-31 | 2002-10-30 | Viragen Inc | Composition of highly purified natural mixtures of type i interferon derived from leukocytes and methods |
EP1118330A1 (en) * | 2000-01-19 | 2001-07-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Interferon-alpha use in the treatment of Ewing's family of tumors |
JP2004522803A (en) * | 2001-06-29 | 2004-07-29 | マキシゲン・エイピーエス | Interferon preparation |
CN1935256A (en) * | 2005-09-22 | 2007-03-28 | 北京远策药业有限责任公司 | Technology for preparing compound human inter feron spray agent capable of preventing polytypic influenza |
CU23432B6 (en) * | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS |
-
2010
- 2010-06-07 RU RU2010122954/15A patent/RU2482871C2/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2576814C1 (en) * | 2014-10-10 | 2016-03-10 | Общество с ограниченной ответственностью "Научно-Технологический Центр "БиоИнвест" | Agent for treatment and prophylaxis of natural infectious diseases in cats |
Also Published As
Publication number | Publication date |
---|---|
RU2482871C2 (en) | 2013-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX345501B (en) | Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid. | |
UA109949C2 (en) | COMPOSITION AND MEDICINAL PRODUCTS CONTAINING IDURONAT-2-SULPHATASE AND METHOD OF OBTAINING THEME | |
BR112015026325A2 (en) | oral dosage of glp-1 compounds | |
BR112014011162A2 (en) | purine derivatives for the treatment of viral infections | |
AU2018236805B2 (en) | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | |
CR20130560A (en) | BEZOTIAZOL COMPOUNDS AND THEIR PHARMACEUTICAL USE | |
UA115043C2 (en) | N-CARBAMIDE-SUBSTITUTED AMINO ACID AMYDIDES AS MODULES OF FORMILPEPTIDE RECEPTOR 1 (FPRL-1) | |
BR112013031268A8 (en) | polypeptides | |
GT200900304A (en) | "CXCR4 CYCLE PEPTIDE ANTAGONISTS" | |
MX342161B (en) | Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders. | |
UY32833A (en) | DP2 ANTAGONISTS AND USES OF THE SAME | |
CR20140134A (en) | PHARMACEUTICAL COMPOSITIONS | |
MX2013003695A (en) | Substituted n-(2-arylamino)aryl sulfonamide-containing combinations. | |
BR112013028679A2 (en) | hepatitis c virus inhibitors | |
EA201490610A1 (en) | CONNECTIONS AND METHODS OF STRENGTHENING CONGENITAL IMMUNE RESPONSES | |
BR112012017188A2 (en) | mgluz agonist compound, its pharmaceutical composition and its use | |
IN2014CN02364A (en) | ||
EA201290374A1 (en) | AEROSOL COMPOSITION FOR COPD | |
MA34055B1 (en) | AGOMELATIN HYDRATE HYDROCHLORIDE AND ITS PREPARATION | |
CL2012000263A1 (en) | Compounds derived from spirocyclic amides, b-adrenoreceptor agonist and muscarinic antagonist; useful in the treatment of inflammatory diseases, such as COPD. | |
EA201590019A1 (en) | DRY POWDER INHALERS, CARRIER CONTAINING, EXCELLENT FROM LACTOSE | |
TR201000733A2 (en) | Pharmaceutical compositions comprising fluticasone, tiotropium and sodium chromoglycate. | |
AR090073A1 (en) | N-ETIL-N-PHENYL-1,2-DIHIDRO-4,5-DI-HYDROXI-1-METHYL-2-OXO-3-CHINOLINACARBOXAMIDE, ITS PREPARATION AND USES | |
CY1113279T1 (en) | PHARMACEUTICAL COMPOSITION 271 | |
EA201490573A1 (en) | CONTAINING BENZOTHIAZOLONE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC41 | Official registration of the transfer of exclusive right |
Effective date: 20150629 |
|
HE4A | Notice of change of address of a patent owner |
Effective date: 20180402 |
|
PD4A | Correction of name of patent owner |